Portfolio Category: BioMed

Getting to Know Dr. James Garner, CEO of Kazia Therapeutics

November 16, 2020

Photo courtesy of Kazia Therapeutics.  BioSpace recently spoke with Dr. James Garner, CEO of Kazia Therapeutics, an oncology company that […]

Read the post

AGT CEO Jeff Galvin on the Future of the Gene and Cell Therapy Industry

April 23, 2020

The rapid growth of biopharma is causing a shift to a new paradigm for the drug development and delivery model. […]

Read the post

Relmada Therapeutics Developing REL-1017 to Treat Major Depression

April 21, 2020

Depression affects hundreds of millions of people worldwide. Relmada Therapeutics is working to develop a treatment for those with depression […]

Read the post

Implications of Pharma Outcomes

September 30, 2019

Oklahoma was the first state to file suit against opioid manufacturers. The success of their legal strategy will have a significant impact on the opioid–and pharmaceutical–industry going forward.

Read the post

Blood Cancer Therapies

September 15, 2019

The story of the science behind the gains in survival rates and the development of ever-more effective therapies is the story of advances in the field of immunotherapy and personalized medicine.

Read the post

Follow us to receive new posts from Science Says

Subscription Form (#2)
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram